Quantifying Amount of Adsorption of Levothyroxine by Percutaneous Endoscopic Gastrostomy Tubes
Background: It has been the authors' clinical experience that hypothyroid patients who achieve a euthyroid state on a steady dose of oral levothyroxine often become hypothyroid over time if the medication is given via a feeding tube. The authors hypothesize that the tubing and enteral feeds may...
Gespeichert in:
Veröffentlicht in: | JPEN. Journal of parenteral and enteral nutrition 2008-03, Vol.32 (2), p.197-200 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: It has been the authors' clinical experience that
hypothyroid patients who achieve a euthyroid state on a steady dose of oral
levothyroxine often become hypothyroid over time if the medication is given
via a feeding tube. The authors hypothesize that the tubing and enteral feeds
may adsorb a significant percentage of the levothyroxine and thereby reduce
its bioavailability. To the authors' knowledge, no previous research has been
reported on this subject. They therefore performed an in vitro assessment of
the degree of levothyroxine adsorption to quantify the amount of drug adsorbed
to the percutaneous endoscopic gastrostomy (PEG) tube and how enteral tube
feeds mitigate or exacerbate this adsorption. Methods: Using
levothyroxine radiolabeled with an I125 tracer, a known dose of
levothyroxine was passed through 60 new PEG tubes. One-half of the tubes were
pretreated with Jevity feeds, and the other half were not. The authors
measured the activity of the radiolabeled levothyroxine before and after it
had passed through the tubes and, using a subtraction analysis, inferred the
amount of thyroxine left within the tube. Results: Tubes presoaked
with feeds had a greater uptake in radioactivity by 326.4 cpm (95% confidence
interval, 226.7-426.1), corresponding to a 45.08% relative increase in uptake
compared with virgin PEG tubes without feeds. Conclusions: Although
the authors found statistically significant differences in mean drug
concentrations, they conclude that the amount of uptake of levothyroxine by
PEG tubes and adsorption of levothyroxine by PEG tubes is probably clinically
insignificant. The differences found may be attributed to the amount of drug
lost during crushing and transfer.
We performed an in-vitro assessment of the degree of levothyroxine adsorption to quantify the amount of drug adsorbed in percutaneous endoscopic gastrotomy (PEG) tubes, and how enteral feeds mitigate or exacerbate this adsorption. |
---|---|
ISSN: | 0148-6071 1941-2444 |
DOI: | 10.1177/0148607108314770 |